Published 2025-01-01
“…Rongping Zhu,1,* Ju Li,2,* Siyan Lian,2,* Yishan Li,3 Meili Cai,2 Yingping Cao,2 Xiaohong Xu2,4 1Department of Blood Transfusion, Fujian Provincial Hospital, Fuzhou
University Affiliated Provincial Hospital, Fuzhou, Fujian, 350001, People’s Republic of
China; 2Department of Laboratory Medicine, Fujian Medical
University Union Hospital, Fuzhou, Fujian, 350001, People’s Republic of
China; 3Anxi County Traditional Chinese Medicine Hospital, Quanzhou, Fujian, 362000, People’s Republic of
China; 4Fujian Medical
University Union Clinical
College, Fuzhou, Fujian, 350001, People’s Republic of
China*These authors contributed equally to this workCorrespondence: Xiaohong Xu; Yingping Cao, Department of Clinical Laboratory, Fujian Medical
University Union Hospital, Fuzhou, Fujian, 350001, People’s Republic of
China, Tel +86 13959192290 ; +86 13365910806, Email vancy1988@163.com; caoyingping@aliyun.comBackground: Therefore, the objectives of this study were to investigate the prevalence of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) in Fujian Medical
University Union Hospital, identify their genetic characters, characterize their resistance profiles, and identify risk factors for their infection to improve prevention and treatment strategies for CR-hvKp in the area.Methods: Between January 2021 and January 2022, clinically identified carbapenem-resistant Klebsiella pneumoniae (CRKp) isolates were collected. …”
Get full text
Article
